ANZMTG Whole Brain Radiotherapy in Melanoma Trial This is a video for patients who have metastatic melanoma with deposits in their brain and for their family and friends. The video describes current treatment of melanoma brain metastases and has interviews with Australian clinicians. The ANZMTG 01.07 WBRT Mel trial is an independent investigator initiated co-operative group trial, sponsored by the Australia and New Zealand Melanoma Trials Group (ANZMTG). Study status - open to recruitment in Australia and Internationally (Norway, England, USA and Brazil). For more information: This trial is registered and listed on the Australia and New Zealand Clinical Trials Registry (ANZCTR# - 12607000512426).